| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |